Sector
PharmaceuticalsOpen
₹0.86Prev. Close
₹0.86Turnover(Lac.)
₹44.35Day's High
₹0.87Day's Low
₹0.8552 Week's High
₹6.4952 Week's Low
₹0.85Book Value
₹1.05Face Value
₹1Mkt Cap (₹ Cr.)
107.95P/E
0EPS
0Divi. Yield
030 Aug 2024
12:00 AM
AGM
Announcement Date: 30 Aug, 2024
27 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
28 May 2025
12:00 AM
Rights
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 76.85 | 76.85 | 10.52 | 4.67 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 7.14 | 6.13 | 11.6 | 17.05 |
Net Worth | 83.99 | 82.98 | 22.12 | 21.72 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 13.74 | 41.66 | 27.49 | |
yoy growth (%) | -67 | 51.53 | 8.7 | |
Raw materials | -7.92 | -13.85 | -10.32 | |
As % of sales | 57.61 | 33.24 | 37.56 | |
Employee costs | -0.51 | -1.2 | -1 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | -0.61 | 5.87 | 3.63 | |
Depreciation | -0.05 | -0.06 | -0.05 | |
Tax paid | 0 | -1.63 | -1.2 | |
Working capital | 0.43 | 2.08 | 16.97 | 5.94 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -67 | 51.53 | 8.7 | |
Op profit growth | -97.93 | 97.54 | 180.52 | |
EBIT growth | -95.96 | 53.39 | 277.52 | |
Net profit growth | -114.37 | 73.99 | 281.08 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Rajnishkumar Surendra Prasad Singh
Independent Director
Monam Kapoor
Independent Director
Swati jain
Non Executive Director
Saloni Mehra
Independent Director
Preeti Garg.
Company Sec. & Compli. Officer
Anupma Kashyap.
Bldg No 3 Navijivan Comm Socie,
6 Th Floor Office No 10L,
Maharashtra - 400008
Tel: 91-22-23065555
Website: http://www.rajnishwellness.com
Email: info@rajnishwellness.com
Office No 56-2,
Pinnacle Busine.Park, Mahakali Caves Road,
Mumbai - 400093
Tel: 91-22-62638200
Website: www.bigshareonline.com
Email: investor@bigshareonline.com
Summary
Rajnish Wellness Limited was originally incorporated on June 13, 2015 as a Private Limited Company under the name and style of Rajnish Hot Deals Private Limited. Subsequently, the Company was converte...
Read More
Reports by Rajnish Wellness Ltd
What is the Rajnish Wellness Ltd share price today?
What is the Market Cap of Rajnish Wellness Ltd?
What is the PE and PB ratio of Rajnish Wellness Ltd?
What is the 52 Week High and Low of Rajnish Wellness Ltd?
What is the CAGR of Rajnish Wellness Ltd?
What is the shareholding pattern of Rajnish Wellness Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.